Drug Profile
Praconase - BioAxone BioSciences
Alternative Names: BA-210; Cethrin; VX-210Latest Information Update: 12 Jul 2022
Price :
$50
*
At a glance
- Originator BioAxone Therapeutic
- Developer BioAxone Biosciences; Vertex Pharmaceuticals
- Class Neuroprotectants; Recombinant fusion proteins
- Mechanism of Action Rho GTP-binding protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Discontinued Age-related macular degeneration; Glaucoma; Optic nerve disorders; Spinal cord injuries